New PSMA scan aims to spot hidden prostate cancer spread
NCT ID NCT04745871
First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 30 times
Summary
This study tested whether a special type of PET/CT scan, called PSMA PET/CT, can better detect if prostate cancer has spread to nearby lymph nodes before surgery. The scan uses a radioactive tracer that sticks to prostate cancer cells, making them visible. The goal was to help doctors plan more precise surgery for men with intermediate- or high-risk prostate cancer. However, the trial was stopped early, so we have less information than planned.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHRU de Brest
Brest, 29609, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PSMA PET/CT scan (a type of imaging test using a radioactive tracer)
What this could lead to
If successful, this imaging test could help doctors more accurately decide the extent of surgery needed for prostate cancer, potentially reducing unnecessary procedures.
What could go wrong
The trial was terminated early, so results are limited. PSMA PET/CT is still being studied and may not be widely available or better than current standard imaging for all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.